Huntington National Bank Novartis Ag Transaction History

Huntington National Bank

$13.4 Billion
Q1 2025

A detailed history of Huntington National Bank transactions in Novartis Ag stock. As of the latest transaction made, Huntington National Bank holds 22,459 shares of NVS stock, worth $2.51 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

22,459

Previous 23,813 5.69%

Holding current value

$2.51 Million

Previous $2.32 Million 8.03%

% of portfolio

0.02%

Previous 0.02%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$97.14 - $115.57 $131,527 - $156,481	-1,354 Reduced 5.69%	22,459 $2.5 Million
Q4 2024 Feb 12, 2025	BUY	$96.78 - $117.18 $121,846 - $147,529	1,259 Added 5.58%	23,813 $2.32 Million
Q3 2024 Nov 06, 2024	SELL	$106.13 - $120.89 $4,032 - $4,593	-38 Reduced 0.17%	22,554 $2.59 Million
Q2 2024 Aug 08, 2024	BUY	$92.57 - $107.37 $97,013 - $112,523	1,048 Added 4.86%	22,592 $2.41 Million
Q1 2024 May 03, 2024	SELL	$95.27 - $108.47 $151,384 - $172,358	-1,589 Reduced 6.87%	21,544 $2.08 Million
Q4 2023 Feb 07, 2024	SELL	$92.27 - $101.54 $6,366 - $7,006	-69 Reduced 0.3%	23,133 $2.34 Million
Q3 2023 Nov 08, 2023	BUY	$94.73 - $105.13 $28,324 - $31,433	299 Added 1.31%	23,202 $2.36 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $22,759 - $25,807	-246 Reduced 1.06%	22,903 $2.31 Million
Q1 2023 May 10, 2023	SELL	$80.03 - $92.81 $72,507 - $84,085	-906 Reduced 3.77%	23,149 $2.13 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $187,666 - $229,819	-2,484 Reduced 9.36%	24,055 $2.18 Million
Q3 2022 Nov 07, 2022	SELL	$74.61 - $87.26 $79,310 - $92,757	-1,063 Reduced 3.85%	26,539 $2.02 Million
Q2 2022 Aug 09, 2022	SELL	$80.52 - $93.75 $35,348 - $41,156	-439 Reduced 1.57%	27,602 $2.33 Million
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $6,088 - $6,887	76 Added 0.27%	28,041 $2.46 Million
Q4 2021 Jan 21, 2022	SELL	$79.7 - $88.13 $9,404 - $10,399	-118 Reduced 0.42%	27,965 $2.45 Million
Q3 2021 Oct 28, 2021	BUY	$81.78 - $95.14 $288,274 - $335,368	3,525 Added 14.35%	28,083 $2.3 Million
Q2 2021 Jul 30, 2021	BUY	$85.24 - $94.15 $607,761 - $671,289	7,130 Added 40.91%	24,558 $2.24 Million
Q1 2021 Apr 12, 2021	BUY	$83.5 - $98.47 $5,511 - $6,499	66 Added 0.38%	17,428 $1.49 Million
Q4 2020 Jan 11, 2021	SELL	$78.07 - $94.43 $137,247 - $166,007	-1,758 Reduced 9.19%	17,362 $1.64 Million
Q3 2020 Oct 30, 2020	SELL	$82.14 - $91.0 $37,209 - $41,223	-453 Reduced 2.31%	19,120 $1.66 Million
Q2 2020 Jul 30, 2020	SELL	$80.93 - $91.1 $49,448 - $55,662	-611 Reduced 3.03%	19,573 $1.71 Million
Q1 2020 Apr 27, 2020	SELL	$70.67 - $99.01 $76,111 - $106,633	-1,077 Reduced 5.07%	20,184 $1.66 Million
Q4 2019 Jan 17, 2020	BUY	$84.35 - $95.37 $212,815 - $240,618	2,523 Added 13.46%	21,261 $2.01 Million
Q3 2019 Nov 01, 2019	SELL	$85.54 - $94.26 $85,882 - $94,637	-1,004 Reduced 5.09%	18,738 $1.63 Million
Q2 2019 Jul 23, 2019	SELL	$75.4 - $92.8 $272,797 - $335,750	-3,618 Reduced 15.49%	19,742 $1.8 Million
Q1 2019 Apr 09, 2019	SELL	$75.32 - $86.15 $115,465 - $132,067	-1,533 Reduced 6.16%	23,360 $2.25 Million
Q4 2018 Jan 28, 2019	SELL	$73.66 - $82.02 $130,599 - $145,421	-1,773 Reduced 6.65%	24,893 $2.14 Million
Q3 2018 Oct 18, 2018	BUY	$66.94 - $77.43 $53,351 - $61,711	797 Added 3.08%	26,666 $2.3 Million
Q2 2018 Jul 19, 2018	BUY	$64.91 - $73.36 $10,125 - $11,444	156 Added 0.61%	25,869 $1.95 Million
Q1 2018 Apr 30, 2018	SELL	$70.39 - $84.15 $92,703 - $110,825	-1,317 Reduced 4.87%	25,713 $2.08 Million
Q4 2017 Feb 02, 2018	SELL	$72.33 - $77.64 $274,347 - $294,488	-3,793 Reduced 12.31%	27,030 $2.27 Million
Q3 2017 Oct 24, 2017	BUY	$74.14 - $77.27 $2.29 Million - $2.38 Million	30,823	30,823 $2.65 Million

Others Institutions Holding NVS

# of Institutions

1,524

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $241B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Novartis Ag Transaction History